| Metric | შპს SmartPharm | სს საქართველოს ბანკი |
|---|---|---|
| Growth | ||
| Revenue | ₾36.6m₾31.6m | ₾2.70bn₾2.32bn |
| Revenue growth | 15.9% | 16.6% |
| Profitability | ||
| EBITDA | ₾2.0m₾3.3m | — |
| EBITDA margin | 5.4%10.4% | — |
| Net profit | ₾1.9m₾2.8m | ₾1.84bn₾1.33bn |
| Net margin | 5.2%8.8% | 68.1%57.6% |
| Balance sheet | ||
| Total assets | ₾16.6m₾13.4m | ₾39.27bn₾31.39bn |
| Total equity | ₾13.1m₾11.6m | ₾5.63bn₾4.45bn |
| ROE | 14.5%23.9% | 32.6%30.0% |